MINNEAPOLIS, Sept. 13, 2017 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile Medical” or the “Company”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the pricing of a previously announced underwritten registered offering by certain of its stockholders of 3,300,000 shares of Tactile Medical common stock at a price to the public of $33.00 per share. In connection with the offering, the selling stockholders have granted the underwriters an option to purchase up to an additional 495,000 shares. Tactile Medical will not receive any proceeds from the offering. The offering is expected to close on or about September 15, 2017, subject to satisfactory completion of customary closing conditions.
Search
New Posts
Mars to Buy Pringles Maker Kellanova for $36 Billion: A Big Deal in the Snack World
Volvo Cars to Deliver First EX90 SUVs This Month After Delay
Housing Market Filled With ‘Wait-and-See’ Home Buyers
AI Dataset Licensing Companies Form Trade Group
New Tom Hanks Film “Here” and the Unsettling ‘De-Aging’ Technology Keeping Stars Forever Young
Leave A Comment